ConductScience.org, home

Paper21391110

Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.

Borde P and 2 others. Nat Prod Res, 2011. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats. Papers, record 21391110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21391110

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.
PubMed
Journal
Nat Prod Res
PubMed
Year
2011
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2022-04-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Borde PPravin
2Mohan MMahalaxmi
3Kasture SSanjay

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
AntioxidantsMajor topic
FlavonoidsMajor topic
HypertensionMajor topic
VitaceaeMajor topic
Angiotensin II
Animals
Blood Pressure
Catalase
Desoxycorticosterone
Disease Models, Animal
Female
Glutathione
Heart Rate
Oxidative Stress
Rats
Rats, Wistar
Serotonin
Sodium Chloride
Superoxide Dismutase
Thiobarbituric Acid Reactive Substances

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
41838190BACH2 ameliorates cell apoptosis and autophagy as a molecular switch of BCL-2/Beclin-1 complex in myocardial infarction.Apoptosis2026https://conductscience.org/library/papers/41838190PubMed
41228490Natural Sweetness and Bioactivity: The Cardiovascular Promise of Fruits.Nutrients2025https://conductscience.org/library/papers/41228490PubMed
40739693Unveiling the Health Potential of Myricetin: Bio-accessibility, Safety Considerations, and Therapeutic Mechanisms.Curr Pharm Des2026https://conductscience.org/library/papers/40739693PubMed
39076470Increased Secreted Frizzled-Related Protein 2 in Hypertension-Induced Left Ventricular Remodeling.Rev Cardiovasc Med2024https://conductscience.org/library/papers/39076470PubMed
38167793Myricetin May Improve Cardiac Dysfunction Possibly Through Regulating Blood Pressure and Cellular Stress Molecules in High-Fructose-Fed Rats.Anatol J Cardiol2024https://conductscience.org/library/papers/38167793PubMed
36339605Grape exosome-like nanoparticles: A potential therapeutic strategy for vascular calcification.Front Pharmacol2022https://conductscience.org/library/papers/36339605PubMed
36091787Effects of Piper sarmentosum Roxb. on hypertension and diabetes mellitus: A systematic review and meta-analysis.Front Pharmacol2022https://conductscience.org/library/papers/36091787PubMed
35281911A Comparative Study of the Antihypertensive and Cardioprotective Potentials of Hot and Cold Aqueous Extracts of Hibiscus sabdariffa L. in Relation to Their Metabolic Profiles.Front Pharmacol2022https://conductscience.org/library/papers/35281911PubMed
34858028Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action.Vasc Health Risk Manag2021https://conductscience.org/library/papers/34858028PubMed
34765268Recent advances in research on vine tea, a potential and functional herbal tea with dihydromyricetin and myricetin as major bioactive compounds.J Pharm Anal2021https://conductscience.org/library/papers/34765268PubMed
33946951Interactions between Phosphatidylcholine and Kaempferol or Myristicin: Langmuir Monolayers and Microelectrophoretic Studies.Int J Mol Sci2021https://conductscience.org/library/papers/33946951PubMed
32738903Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.BMC Complement Med Ther2020https://conductscience.org/library/papers/32738903PubMed
31885808Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway.Oxid Med Cell Longev2019https://conductscience.org/library/papers/31885808PubMed
31309069Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by Avicenna's Canon of Medicine.Avicenna J Phytomed2019https://conductscience.org/library/papers/31309069PubMed
30825074Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.Eur J Drug Metab Pharmacokinet2019https://conductscience.org/library/papers/30825074PubMed
26891321Myricetin: A Dietary Molecule with Diverse Biological Activities.Nutrients2016https://conductscience.org/library/papers/26891321PubMed
25234650Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension.Mol Biol Rep2015https://conductscience.org/library/papers/25234650PubMed
22526544Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.Psychopharmacology (Berl)2012https://conductscience.org/library/papers/22526544PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21391110

GET https://conductscience.org/api/papers/v1/21391110/authors